Logo image of LINE

LINEAGE INC (LINE) Stock Fundamental Analysis

USA - NASDAQ:LINE - US53566V1061 - REIT

39.33 USD
-0.07 (-0.18%)
Last: 11/3/2025, 8:06:43 PM
39.33 USD
0 (0%)
After Hours: 11/3/2025, 8:06:43 PM
Fundamental Rating

2

LINE gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 127 industry peers in the Diversified REITs industry. LINE may be in some trouble as it scores bad on both profitability and health. LINE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

LINE had negative earnings in the past year.
LINE had a positive operating cash flow in the past year.
LINE Yearly Net Income VS EBIT VS OCF VS FCFLINE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 500M -500M

1.2 Ratios

The Return On Assets of LINE (-2.82%) is worse than 76.38% of its industry peers.
The Return On Equity of LINE (-6.36%) is worse than 69.29% of its industry peers.
The Return On Invested Capital of LINE (1.10%) is worse than 81.10% of its industry peers.
The Average Return On Invested Capital over the past 3 years for LINE is in line with the industry average of 3.06%.
Industry RankSector Rank
ROA -2.82%
ROE -6.36%
ROIC 1.1%
ROA(3y)-1.44%
ROA(5y)N/A
ROE(3y)-3.48%
ROE(5y)N/A
ROIC(3y)1.85%
ROIC(5y)N/A
LINE Yearly ROA, ROE, ROICLINE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 2 -2 -4 -6

1.3 Margins

Looking at the Operating Margin, with a value of 4.70%, LINE is doing worse than 85.83% of the companies in the same industry.
In the last couple of years the Operating Margin of LINE has remained more or less at the same level.
Looking at the Gross Margin, with a value of 32.30%, LINE is doing worse than 88.19% of the companies in the same industry.
LINE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.7%
PM (TTM) N/A
GM 32.3%
OM growth 3Y0.12%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.87%
GM growth 5YN/A
LINE Yearly Profit, Operating, Gross MarginsLINE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 10 -10 20 30

3

2. Health

2.1 Basic Checks

LINE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, LINE has more shares outstanding
LINE has a better debt/assets ratio than last year.
LINE Yearly Shares OutstandingLINE Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 50M 100M 150M 200M
LINE Yearly Total Debt VS Total AssetsLINE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

LINE has an Altman-Z score of 0.66. This is a bad value and indicates that LINE is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.66, LINE perfoms like the industry average, outperforming 58.27% of the companies in the same industry.
The Debt to FCF ratio of LINE is 42.17, which is on the high side as it means it would take LINE, 42.17 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 42.17, LINE is doing good in the industry, outperforming 66.14% of the companies in the same industry.
LINE has a Debt/Equity ratio of 0.81. This is a neutral value indicating LINE is somewhat dependend on debt financing.
LINE's Debt to Equity ratio of 0.81 is fine compared to the rest of the industry. LINE outperforms 73.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 42.17
Altman-Z 0.66
ROIC/WACC0.15
WACC7.13%
LINE Yearly LT Debt VS Equity VS FCFLINE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

LINE has a Current Ratio of 0.96. This is a bad value and indicates that LINE is not financially healthy enough and could expect problems in meeting its short term obligations.
LINE has a Current ratio (0.96) which is comparable to the rest of the industry.
A Quick Ratio of 0.83 indicates that LINE may have some problems paying its short term obligations.
LINE has a Quick ratio of 0.83. This is comparable to the rest of the industry: LINE outperforms 46.46% of its industry peers.
Industry RankSector Rank
Current Ratio 0.96
Quick Ratio 0.83
LINE Yearly Current Assets VS Current LiabilitesLINE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 500M 1B

3

3. Growth

3.1 Past

LINE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -887.61%.
LINE shows a decrease in Revenue. In the last year, the revenue decreased by -0.03%.
Measured over the past years, LINE shows a quite strong growth in Revenue. The Revenue has been growing by 12.99% on average per year.
EPS 1Y (TTM)-887.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%82.61%
Revenue 1Y (TTM)-0.03%
Revenue growth 3Y12.99%
Revenue growth 5YN/A
Sales Q2Q%0.9%

3.2 Future

Based on estimates for the next years, LINE will show a very strong growth in Earnings Per Share. The EPS will grow by 27.50% on average per year.
LINE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.45% yearly.
EPS Next Y90.14%
EPS Next 2Y40.63%
EPS Next 3Y27.5%
EPS Next 5YN/A
Revenue Next Year1.47%
Revenue Next 2Y2.78%
Revenue Next 3Y3.45%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
LINE Yearly Revenue VS EstimatesLINE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
LINE Yearly EPS VS EstimatesLINE Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0 -1 -2

1

4. Valuation

4.1 Price/Earnings Ratio

LINE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LINE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LINE Price Earnings VS Forward Price EarningsLINE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600

4.2 Price Multiples

LINE's Enterprise Value to EBITDA is on the same level as the industry average.
LINE's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 53.56
EV/EBITDA 14.15
LINE Per share dataLINE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

A more expensive valuation may be justified as LINE's earnings are expected to grow with 27.50% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.63%
EPS Next 3Y27.5%

4

5. Dividend

5.1 Amount

LINE has a Yearly Dividend Yield of 5.41%, which is a nice return.
Compared to an average industry Dividend Yield of 6.40, LINE has a dividend in line with its industry peers.
LINE's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 5.41%

5.2 History

LINE has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
LINE Yearly Dividends per shareLINE Yearly Dividends per shareYearly Dividends per share 2024 2025 0.5 1 1.5

5.3 Sustainability

DPN/A
EPS Next 2Y40.63%
EPS Next 3Y27.5%
LINE Yearly Income VS Free CF VS DividendLINE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 0 -200M -400M -600M

LINEAGE INC

NASDAQ:LINE (11/3/2025, 8:06:43 PM)

After market: 39.33 0 (0%)

39.33

-0.07 (-0.18%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-05 2025-11-05/bmo
Inst Owners33.48%
Inst Owner Change-0.57%
Ins Owners0.2%
Ins Owner Change0.06%
Market Cap9.00B
Revenue(TTM)5.32B
Net Income(TTM)-549000000
Analysts69.6
Price Target48.66 (23.72%)
Short Float %5.63%
Short Ratio3.51
Dividend
Industry RankSector Rank
Dividend Yield 5.41%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date09-30 2025-09-30 (0.5275)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-40.84%
Min EPS beat(2)-46.03%
Max EPS beat(2)-35.66%
EPS beat(4)0
Avg EPS beat(4)-162.35%
Min EPS beat(4)-466.27%
Max EPS beat(4)-35.66%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3%
Min Revenue beat(2)-5.42%
Max Revenue beat(2)-0.59%
Revenue beat(4)0
Avg Revenue beat(4)-2.33%
Min Revenue beat(4)-5.42%
Max Revenue beat(4)-0.59%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.25%
PT rev (3m)-13.17%
EPS NQ rev (1m)-154.54%
EPS NQ rev (3m)-204.63%
EPS NY rev (1m)-223.53%
EPS NY rev (3m)-275.02%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.84%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.16%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.69
P/FCF 53.56
P/OCF 10.71
P/B 1.04
P/tB 2.26
EV/EBITDA 14.15
EPS(TTM)-2.93
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)0.73
FCFY1.87%
OCF(TTM)3.67
OCFY9.34%
SpS23.24
BVpS37.75
TBVpS17.41
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.82%
ROE -6.36%
ROCE 1.39%
ROIC 1.1%
ROICexc 1.1%
ROICexgc 1.49%
OM 4.7%
PM (TTM) N/A
GM 32.3%
FCFM 3.16%
ROA(3y)-1.44%
ROA(5y)N/A
ROE(3y)-3.48%
ROE(5y)N/A
ROIC(3y)1.85%
ROIC(5y)N/A
ROICexc(3y)1.86%
ROICexc(5y)N/A
ROICexgc(3y)2.54%
ROICexgc(5y)N/A
ROCE(3y)2.34%
ROCE(5y)N/A
ROICexgc growth 3Y8.4%
ROICexgc growth 5YN/A
ROICexc growth 3Y8.9%
ROICexc growth 5YN/A
OM growth 3Y0.12%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.87%
GM growth 5YN/A
F-Score4
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 42.17
Debt/EBITDA 6.16
Cap/Depr 76.19%
Cap/Sales 12.64%
Interest Coverage 0.7
Cash Conversion 74.2%
Profit Quality N/A
Current Ratio 0.96
Quick Ratio 0.83
Altman-Z 0.66
F-Score4
WACC7.13%
ROIC/WACC0.15
Cap/Depr(3y)99.91%
Cap/Depr(5y)N/A
Cap/Sales(3y)14.59%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-887.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%82.61%
EPS Next Y90.14%
EPS Next 2Y40.63%
EPS Next 3Y27.5%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.03%
Revenue growth 3Y12.99%
Revenue growth 5YN/A
Sales Q2Q%0.9%
Revenue Next Year1.47%
Revenue Next 2Y2.78%
Revenue Next 3Y3.45%
Revenue Next 5YN/A
EBIT growth 1Y-29.21%
EBIT growth 3Y13.12%
EBIT growth 5YN/A
EBIT Next Year378.8%
EBIT Next 3Y77.15%
EBIT Next 5YN/A
FCF growth 1Y-59.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.58%
OCF growth 3Y28.68%
OCF growth 5YN/A

LINEAGE INC / LINE FAQ

What is the fundamental rating for LINE stock?

ChartMill assigns a fundamental rating of 2 / 10 to LINE.


What is the valuation status of LINEAGE INC (LINE) stock?

ChartMill assigns a valuation rating of 1 / 10 to LINEAGE INC (LINE). This can be considered as Overvalued.


How profitable is LINEAGE INC (LINE) stock?

LINEAGE INC (LINE) has a profitability rating of 1 / 10.


Can you provide the financial health for LINE stock?

The financial health rating of LINEAGE INC (LINE) is 3 / 10.


What is the expected EPS growth for LINEAGE INC (LINE) stock?

The Earnings per Share (EPS) of LINEAGE INC (LINE) is expected to grow by 90.14% in the next year.